The US Food and Drug Administration (FDA) just announced that it has increased employee bonuses by a whopping 29 percent in the past year, despite earlier objections from lawmakers, its ongoing complaints over inadequate funding, and a number of embarrassing and widely publicized blunders, including one that allowed tainted heparin into the country.
For year ending April 12, the FDA paid out $35 million in staff incentives, a figure that is a significant increase from the $27.1 million it paid the prior year, according to records posted on the House Energy and Commerce Committee’s Website. Just last year, lawmakers complained that the FDA was issuing too many bonuses, especially to high-ranking officials. This recent increase, which was shown in the latest records provided by the FDA, has prompted renewed objections by Representative Bart Stupack—Democrat-Michigan—chairman of the panel’s investigative subcommittee. “It is outrageous that bonuses for top officials at FDA increased by nearly 30 percent over the past year despite the agency’s poor management,” Stupak said “These bonuses are not going to the men and women in the field who FDA struggles to retain. They’re going to top agency officials in Washington who have presided over the agency while an unprecedented number of Americans have been sickened by contaminated food and drugs.” (more…)

